SCHEMBL28501476

SCHEMBL28501476

CC(=O)Cc1ccc(-c2ccc3ccccc3c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.52
ESR2 Q92731 1/20 0.52
ABCC4 O15439 1/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
TSHR P16473 1/20 0.47
PTGS1 P23219 1/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 2/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ACMSD Q8TDX5 1/20 0.46
ALOX5 P09917 1/20 0.46
CYP1A2 P05177 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 1/20 0.45
HIF1A Q16665 1/20 0.45
CA1 P00915 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2305222 0.87 HSD17B1 (0.50) ESR1ESR2KDM4EHPGDSMN1; SMN2
SCHEMBL265881 0.85 L3MBTL1 (0.56) KDM4EHPGDSMN1; SMN2ALOX5CYP1A2
SCHEMBL6242519 0.84 ABCC4 (0.69) ESR1ESR2ABCC4LMNAGAA
SCHEMBL6296732 0.82 CYP11B1 (0.54) ESR1ESR2HPGDSMN1; SMN2MEN1
SCHEMBL1928476 0.81 LMNA (0.69) ABCC4LMNAGAATSHRPTGS1
SCHEMBL18537208 0.80 L3MBTL1 (0.51) PTGS1KDM4EHPGDSMN1; SMN2ALOX5
SCHEMBL13478513 0.79 RXRA (0.50) ESR1ABCC4LMNAGAATSHR
SCHEMBL12243166 0.79 MAPT (0.53) ESR1ESR2LMNAGAAKDM4E
SCHEMBL5048312 0.77 SLC6A2 (0.51) ESR1ESR2TSHRKDM4EHPGD
SCHEMBL18260221 0.77 MAPT (0.64) ESR1ESR2LMNAGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108117516-B Preparation method and application of polysubstituted pyridine derivative 浙江工业大学 2021-01-19 CN disclosed